Grünenthal licenses exclusive Australian rights to Qutenza® to Clinect
18.03.2026 - 01:34:54 | prnewswire.co.ukAbout Clinect
Clinect is part of the EBOS Group the largest and most diversified Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. Clinect supports patients in Australia and New Zealand with established and innovative products via strategic partnering relationships. Clinect together with its affiliates, will market and distribute the product in Australia.
Media Contacts
Grünenthal
Maren Thurow
Head Global Communication
Phone: +44 7917 196855
Maren.Thurow@grunenthal.com
Clinect
John Bennetts
Head of Communication and Corporate Affairs
Phone: +61 498 000 897
John.Bennetts@ebosgroup.com
View original content:https://www.prnewswire.co.uk/news-releases/grunenthal-licenses-exclusive-australian-rights-to-qutenza-to-clinect-302695471.html
So schätzen Börsenprofis die Aktie ein. Verpasse keine Chance mehr.
Für. Immer. Kostenlos.

